DrugPatentWatch Database Preview
Details for Patent: 10,016,504
Which drugs does patent 10,016,504 protect, and when does it expire?
Patent 10,016,504 protects PLENVU and is included in one NDA.
This patent has forty-five patent family members in twenty-four countries.
Summary for Patent: 10,016,504
| Title: | Compositions |
| Abstract: | The invention provides a colon cleansing solution comprising: a) 300 to 800 mmol per liter ascorbate anion provided by a mixture of: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per liter polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions, and compositions for the preparation of the solutions. |
| Inventor(s): | Clayton; Lucy (Uxbridge, GB), Cockett; Alasdair (Uxbridge, GB), Christodoulou; Mark (Uxbridge, GB), Davidson; Ian (Uxbridge, GB), Farrag; Lynn (Uxbridge, GB), Halphen; Marc (London, GB), Jones; Leighton (Uxbridge, GB), Petrossian; Vanik (Woburn, MA), Stein; Peter (Amsterdam Zuid-Oost, NL), Tisi; David (Woburn, MA), Ungar; Alex (Wigton, GB), Worthington; Jeffrey (Woburn, MA) |
| Assignee: | NORGINE BV (Amsterdam Zuid-Oost, NL) |
| Application Number: | 15/454,132 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,016,504 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Process; |
Drugs Protected by US Patent 10,016,504
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salix | PLENVU | ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate | FOR SOLUTION;ORAL | 209381-001 | May 4, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,016,504
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 092500 | Start Trial | |||
| Australia | 2013314442 | Start Trial | |||
| Australia | 2015228962 | Start Trial | |||
| Australia | 2018204694 | Start Trial | |||
| Brazil | 112015005270 | Start Trial | |||
| Canada | 2884472 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
